Control Bionics (ASX:CBL) COGS-to-Revenue : 0.28 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Control Bionics COGS-to-Revenue?

Control Bionics's Cost of Goods Sold for the six months ended in Dec. 2023 was A$0.80 Mil. Its Revenue for the six months ended in Dec. 2023 was A$2.84 Mil.

Control Bionics's COGS to Revenue for the six months ended in Dec. 2023 was 0.28.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Control Bionics's Gross Margin % for the six months ended in Dec. 2023 was 72.04%.

Control Bionics COGS-to-Revenue Historical Data

The historical data trend for Control Bionics's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Control Bionics COGS-to-Revenue Chart

Control Bionics Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

COGS-to-Revenue

0.36

0.45

0.36

Control Bionics Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial			0.42	0.49	0.44	0.27	0.28

Control Bionics COGS-to-Revenue Calculation

Control Bionics's COGS to Revenue for the fiscal year that ended in Jun. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1.931	/	5.435
	=	0.36

Control Bionics's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.795	/	2.843
	=	0.28

Control Bionics (ASX:CBL) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Control Bionics's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.795 / 2.843
	=	72.04 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Control Bionics COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Control Bionics's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Control Bionics (ASX:CBL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Control Bionics Ltd (ASX:CBL) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

697 Bourke Road, Suite 5.01, Camberwell, Melbourne, VIC, AUS, 3124

Website

https://www.controlbionics.com

Control Bionics Ltd is engaged in the business of healthcare devices. It is engaged in the development, commercialization, and sale of assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically it derives a majority of revenue from North America and has its presence in Australia as well.